Prestige Consumer Healthcare INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Prestige Consumer Healthcare Inc. has released its 2026 Proxy Statement, detailing upcoming annual meeting agenda items, director nominations, executive compensation, and corporate governance.
NYSE
DEF 14A: Prestige Consumer Healthcare Achieves Record Fiscal 2025 Results Amidst Challenging Environment
Prestige Consumer Healthcare Inc. reported record revenues, adjusted earnings per share, and strong free cash flow for fiscal year 2025, demonstrating consistent growth and strategic execution.
NYSE
Prestige Consumer Healthcare Inc. is holding its 2024 Annual Meeting of Stockholders on August 6, 2024, to vote on key proposals including the election of directors, ratification of the independent auditor, executive compensation, and an amendment to the company's certificate of incorporation.